2011-2013年武汉市部分医院氟喹诺酮类药物应用分析

发布时间：2019-02-18 10:02

【摘要】：目的了解氟喹诺酮类抗菌药物使用情况,为合理用药提供依据。方法对2011-2013年武汉市34家医院氟喹诺酮类药使用数量和消耗金额进行统计分析。结果 3年中,氟喹诺酮类抗菌药物年销售金额在11 000万元~12 000万元,除注射剂和口服剂外,眼用制剂逐步占有一定的市场,年度用药金额在6%左右。除左氧氟沙星、莫西沙星销售金额靠前且呈上升趋势外,加替沙星、帕珠沙星和司帕沙星等呈骤降趋势,吉米沙星、芦氟沙星等部分产品已逐渐退出该地区。结论该地区氟喹诺酮类抗菌药物的监管进一步取得成效,用药数据与过去3年相比,用量及品种渐趋合理。
[Abstract]:Objective To study the use of the anti-bacterials of the fluoronone type, and provide the basis for the rational use of the drugs. Methods The use quantity and consumption amount of florfenone type drug in 34 hospitals in Wuhan, 2011-2013 were analyzed and analyzed. Results In the 3-year period, the annual sales amount of the anti-bacterial drug of the fluticorone was in the range of 11 million yuan to 12 million yuan. In addition to the injection and the oral agent, the eye-use preparations gradually occupy a certain market, and the annual medication amount is about 6%. In addition to levofloxacin and moxifloxacin, the sales amount of Moxifloxacin was on the rise, and some of the products, such as the Gatifloxacin, Pazufloxacin and Spatina, have gradually dropped out of the area. Conclusion The supervision of the anti-bacterial drugs in the region of the region is more effective than that in the past three years, and the dosage and variety of the drug are more and more reasonable.
【作者单位】：华中科技大学同济医学院附属同济医院药学部;宜城市中医医院药剂科;
【分类号】：R95

【参考文献】